The company's Irys genome mapping technology provides researchers with a non-sequencing-based tool that is essential for studying structural variation.
The public-private consortium, led by the National Institute of Standards and Technology, recently released four new reference materials.
At a workshop organized by the Genome in a Bottle consortium last month, Nabsys presented its human genome maps for the first time.
BioNano plans to develop structural variant assays on its Irys system for diagnostic use in China as a first step in bringing its technology to the clinic.
BGI has signed an agreement to offer NRGene's bioinformatics tools as part of its agricultural genomic analysis service to customers in Asia.
Researchers at the Joint Genome Institute and elsewhere have been working on understanding the genomes of switchgrass and a close relative in order to use the plants to make better biofuels.
After closing its doors last September, Nabsys has resumed operations, refocusing on its core technology.
Access to the full genome map is expected to boost efforts to develop more resistant, higher-yield varieties of wheat.
Gene Company will distribute BioNano's Irys genome mapping system in China, except for Shanghai, with exclusive rights in Hong Kong and Macau.
A Mount Sinai-led team of researchers combined the technologies to generate de novo assemblies and get a better view of structural variations.
In Science this week: metagenomic-based technique for determining protein structure, and more.
An academic laments the rise of narcissism in the sciences, the Guardian reports.
Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.
The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.